Malignant obstructive jaundice: the role of percutaneous metallic stents
D'alincourt, A.; Hamy, A.; Thibaud, C.; Redon, H.; Paineau, J.; Lerat, F.
Gastroenterologie Clinique et Biologique 24(8-9): 770-775
2000
ISSN/ISBN: 0399-8320 PMID: 11011256 Document Number: 519208
Objectives: Efficiency evaluation of percutaneous metallic stents in palliative treatment of malignant biliary obstruction. Methods: One hundred sixteen percutaneous metallic stents were implanted in 80 patients with malignant biliary obstruction. Thirty-five patients had hilar obstruction, 32 patients obstruction of the common bile duct and 12 patients obstruction of a bilioenteric anastomosis. Results: Adequate biliary drainage was achieved in 79 patients. Early complications occurred in 23.75% of patients; 12.5% of patients died within 30 days. The procedure-related mortality rate was 5%; 18.75% of patients showed recurrent jaundice after an average of 175 days. Conclusion: Percutaneous metallic stents are an efficient means of treating malignant biliary strictures, particularly of upper biliary obstructions. However, this treatment has risks and limits that require careful patient recruitment.